Your browser doesn't support javascript.
loading
Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study.
Silverberg, J I; Pinter, A; Alavi, A; Lynde, C; Bouaziz, J-D; Wollenberg, A; Murrell, D F; Alpizar, S; Laquer, V; Chaouche, K; Ahmad, F; Armstrong, J M; Piketty, C.
Afiliação
  • Silverberg JI; Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
  • Pinter A; Department of Dermatology, Venereology, and Allergology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany.
  • Alavi A; Department of Dermatology, Mayo Clinic, Rochester, MN, USA.
  • Lynde C; Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Bouaziz JD; Department of Dermatology, Paris VII Sorbonne Paris Cité University Assistance Publique - Hôpitaux de Paris, Paris, France.
  • Wollenberg A; Department of Dermatology and Allergology, Ludwig-Maximilians-Universität, Munich, Germany.
  • Murrell DF; Department of Dermatology, St George Clinical School, University of New South Wales, Sydney, NSW, Australia.
  • Alpizar S; Clinical Research Trials of Florida, Tampa, FL, USA.
  • Laquer V; First OC Dermatology, Fountain Valley, CA, USA.
  • Chaouche K; Galderma, Entre-Deux-Villes, Switzerland.
  • Ahmad F; Galderma Laboratories, Fort Worth, TX, USA.
  • Armstrong JM; Galderma, Entre-Deux-Villes, Switzerland.
  • Piketty C; Galderma, Entre-Deux-Villes, Switzerland.
J Eur Acad Dermatol Venereol ; 35(7): 1562-1568, 2021 Jul.
Article em En | MEDLINE | ID: mdl-33711179

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatite Atópica / Eczema Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatite Atópica / Eczema Idioma: En Ano de publicação: 2021 Tipo de documento: Article